Profiles of some of the academic staff who contribute to the course
Yanick Crow
Yanick Crow is Professor of Genetic Medicine at the University of Manchester. His research has two main themes; the pathogenesis of the complex disorder systemic lupus erythematosus (SLE) by looking at Mendelian forms of SLE such as Aicardi Goutieres syndrome, and the genetic basis of paediatric disorders with intracranial calcification.
Caroline Dive
Caroline Dive is Professor of Pharmacology and Pharmacy at the Paterson Institute for Cancer Research. She is Co-Director of the Clinical and Experimental Pharmacology Group, which carries out biomarker-focused translational research of therapies that promote tumour apoptosis and those that prevent tumour angiogenesis.
Andrew Doig
Professor Andrew Doig is in The Structural and Functional Systems research group in the Faculty of Life Sciences. His research interests include design of inhibitors against peptides or proteins which aggregate into beta-sheet fibrils in the brain, causing many major diseases, such as Alzheimer's, Parkinson’s and type II diabetes.
Peter Fielden
Peter Fielden is Professor of Analytical Science within the School of Chemical Engineering and Analytical Science, based at the Manchester Interdisciplinary Biocentre. His key research interests are in analytical separation techniques, implementation of microfluidic chemical and biochemical analysis techniques and platforms for quantitative analytical and high throughput experimentation, and electrochemical sensors and electroanalytical measurements.
Roy Goodacre
Roy Goodacre is Professor of Biological Chemistry, based at the Manchester Interdisciplinary Biocentre. His research interests are broadly within analytical biotechnology and systems biology and advanced data analysis applied to spectroscopic, mass spectrometric and metabolomics data. Roy has published approximately 180 peer-reviewed papers and co-edited several books.
Malcolm Ranson
Malcolm Ranson is Professor of Medical Oncology and Pharmacology. He is an Honorary Consultant at the Christie Hospital and leads a team of clinical researchers at the Derek Crowther Trials Unit; one of the largest early-phase clinical research units in Europe, conducting Phase I clinical trials focused on apoptosis, cell signalling and biomarker development.
John Waterton
John Waterton is Professor of Translational Imaging, with an interest in whole-body imaging techniques and in particular, magnetic resonance imaging. His research interest is in identifying magnetic resonance phenomena and translating them from the laboratory into clinical biomarkers which help diagnose, treat and prevent disease, including cancer, arthritis, diabetes and respiratory diseases.
Tony Whetton
Tony Whetton is Head of School of Cancer and Enabling Sciences and Professor of Cancer Cell Biology. His research interests focus on the use of proteomics techniques to understand biological processes in normal and leukemic hematopoietic stem cells and to discover new biomarkers associated with cancers.